Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Conference News ESC 2025

ESC/EACTS Release New Valvular Heart Disease Guidelines

Yael L. Maxwell

September 03, 2025

News Daily News

Jean-Philippe Collet, Thrombosis Expert and Trialist, Dies at 59

Yael L. Maxwell

December 18, 2023

News Conference News PCR London Valves 2023

Looking for a Winner Between Long-term TAVI Trials? Don’t, Experts Urge

Shelley Wood

November 27, 2023

News Daily News

New Microbleeds Not Uncommon Post-TAVI

Caitlin E. Cox

August 10, 2022

News Daily News

PARTNER Data Back 5-Year Durability of Sapien 3 TAVR

Caitlin E. Cox

October 12, 2020

News Daily News

Functionally Significant Nonculprit Lesions Pose Risk in STEMI Patients

Michael O'Riordan

April 21, 2020

News Daily News

Diabetes Does Not Appear to Hinder FFR Insights for CAD

Caitlin E. Cox

January 09, 2020

News Conference News AHA 2019

TAVR Valve Face-off: Two French Observational Studies Suggest Inherent Differences

Yael L. Maxwell

November 18, 2019

News Daily News

Routine Use of FFR, iFR Changes Treatment Plans, Even in Patients With Multivessel Disease

Todd Neale

February 21, 2018

News Conference News ACC 2017

Post-TAVR, Nearly a Quarter of Patients Show New Signs of Silent Cerebral Microbleeds on MRI

Caitlin E. Cox

March 20, 2017

News Conference News EuroPCR 2016

Registry Data Help Shore Up the Case for Functional Assessment in ACS, Multivessel Disease

Caitlin E. Cox

May 19, 2016

News Conference News ESC 2014

FRANCE2: Registry Shows Positive Outcomes for TAVR in High-Risk Diabetic Patients

Yael L. Maxwell

September 02, 2014

News Daily News

La Regurgitación Aórtica se Confirma como un Potente Predictor de la Mortalidad tras TAVR

L.A. McKeown

March 05, 2014

News Daily News

Aortic Regurgitation Confirmed as Powerful Mortality Predictor after TAVR

L.A. McKeown

March 05, 2014

News Conference News AHA 2013

AHA 2013: Mix of Positive, Negative Trials Help Guide Interventional Practice

November 24, 2013

News Conference News AHA 2013

French Registry: FFR Safely Reclassifies Almost Half of Revascularization Patients

Yael L. Maxwell

November 20, 2013

News Conference News ESC 2013

FRANCE 2: Post-TAVR Aortic Regurgitation Doubles Mortality Risk

Caitlin E. Cox

September 02, 2013

Advertisement

ESC/EACTS Release New Valvular Heart Disease Guidelines

Jean-Philippe Collet, Thrombosis Expert and Trialist, Dies at 59

Looking for a Winner Between Long-term TAVI Trials? Don’t, Experts Urge

New Microbleeds Not Uncommon Post-TAVI

PARTNER Data Back 5-Year Durability of Sapien 3 TAVR

Functionally Significant Nonculprit Lesions Pose Risk in STEMI Patients

Diabetes Does Not Appear to Hinder FFR Insights for CAD

TAVR Valve Face-off: Two French Observational Studies Suggest Inherent Differences

Routine Use of FFR, iFR Changes Treatment Plans, Even in Patients With Multivessel Disease

Post-TAVR, Nearly a Quarter of Patients Show New Signs of Silent Cerebral Microbleeds on MRI

Registry Data Help Shore Up the Case for Functional Assessment in ACS, Multivessel Disease

FRANCE2: Registry Shows Positive Outcomes for TAVR in High-Risk Diabetic Patients

La Regurgitación Aórtica se Confirma como un Potente Predictor de la Mortalidad tras TAVR

Aortic Regurgitation Confirmed as Powerful Mortality Predictor after TAVR

AHA 2013: Mix of Positive, Negative Trials Help Guide Interventional Practice

French Registry: FFR Safely Reclassifies Almost Half of Revascularization Patients

FRANCE 2: Post-TAVR Aortic Regurgitation Doubles Mortality Risk

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content